Work

Recent progress in genetic and epigenetic research on type 2 diabetes

Year: 2016
Type: review
Abstract: Type 2 diabetes (T2DM) is a common complex metabolic disorder that has a strong genetic predisposition. During the past decade, progress in genetic association studies has enabled the identification of at least 75 independent genetic loci for T2DM, thus allowing a better understanding of the genetic architecture of T2DM. International collaborations and large-scale meta-analyses of genome-wide association studies have made these achievements possible. However, whether the identified common variants are causal is largely unknown. In addition, the detailed mechanism of how these genetic variants exert their effect on the pathogenesis of T2DM requires further investigation. Currently, there are ongoing large-scale sequencing studies to identify rare, functional variants for T2DM. Environmental factors also have a crucial role in the development of T2DM. These could modulate gene expression via epigenetic mechanisms, including DNA methylation, histone modification and microRNA regulation. There is evidence that epigenetic changes are important in the development of T2DM. Recent studies have identified several DNA methylation markers of T2DM from peripheral blood and pancreatic islets. In this review, we will briefly summarize the recent progress in the genetic and epigenetic research on T2DM and discuss how environmental factors, genetics and epigenetics can interact in the pathogenesis of T2DM. Environmental factors, genetics and markers on DNA all interact in the development of type 2 diabetes, a debilitating metabolic disorder. In a review article, Kyong Soo Park and colleague at Seoul National University, South Korea, discuss recent progress on understanding the genetic diversity of type 2 diabetes and how chemical tags on DNA known as epigenetic markers affect gene regulation and contribute to disease. Scientists have identified more than 75 genetic variants associated with type 2 diabetes, although the mechanism by which most of these variants cause disease remains unknown. New technologies are now being deployed to sequence entire genomes or to systematically probe epigenetic markers and understand how they change in response to environmental stimuli. This detailed information should help personalize treatments and improve outcomes for people living with the disease.
Language: English
Subfield: Genetics
Open Access status: gold
Estimated APC paid: $4,490
OpenAlex ID: W2293182033
FWCI: 2.659
Cites: 67
Cited by: 250
Related to: 10